$EDIT Editas Medicine, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Editas Medicine, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Editas Medicine, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Editas Medicine, Inc. for free.

CIK Number: 0001650664
IRS Number: 464097528
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: EDIT
Company Address: 11 HURLEY ST. CAMBRIDGE 02141
Phone number: 617-401-9000

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

Market Capitalization: $636.78M
Prev close: $18.56
Average Daily Volume: 358,194
Days Low: $17.70
Year Low: $12.43
Year High: $43.99

Editas Medicine, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Collins CynthiaCEO43,760812,186shares bought: 52,191 / shares sold: -8,431 STRONG BUYFeb 10 20213 months ago
Hopfield JessicaDirector22,700421,312shares bought: 22,700 / shares sold: 0 STRONG BUYMar 05 20212 months ago
MULLEN JAMES CCEO35,000649,600shares bought: 35,000 / shares sold: 0 STRONG BUYMar 04 20212 months ago

View all Editas Medicine, Inc. insiders.

Editas Medicine, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 05 2021EDITEditas Medicine, I ...Hopfield JessicaDirectorBuyP45.515,800263,97022,70016.9 K to 22.7 K (+34.32 %)
Mar 04 2021EDITEditas Medicine, I ...MULLEN JAMES CCEOOption ExerciseA45.69196,6378,984,345196,637
Mar 04 2021EDITEditas Medicine, I ...MULLEN JAMES CCEOBuyP46.2725,0001,156,80035,00010 K to 35 K (+250.00 %)
Feb 10 2021EDITEditas Medicine, I ...Collins CynthiaCEOSellS66.651,26284,11243,76045 K to 43.8 K (-2.80 %)
Jan 13 2021EDITEditas Medicine, I ...ROBERTSON MICHELLEChief Financial Off ...SellS78.271,568122,72718,43220 K to 18.4 K (-7.84 %)
Dec 18 2020EDITEditas Medicine, I ...Chatterjee MeetaDirectorOption ExerciseA62.7123,0761,447,09623,076
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...Option ExerciseM16.5110,000165,100145,000
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...SellS64.3920012,87824,90725.1 K to 24.9 K (-0.80 %)
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...SellS63.844,024256,89225,10729.1 K to 25.1 K (-13.81 %)
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...SellS62.745,776362,38629,13134.9 K to 29.1 K (-16.55 %)
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...BuyM16.5110,000165,10034,90724.9 K to 34.9 K (+40.15 %)
Dec 11 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...Option ExerciseM16.5110,000165,100155,000
Dec 11 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...SellS45.0010,000450,00024,90734.9 K to 24.9 K (-28.65 %)
Dec 11 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...BuyM16.5110,000165,10034,90724.9 K to 34.9 K (+40.15 %)
Dec 08 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...Option ExerciseM16.5120,000330,200165,000

View all Editas Medicine, Inc. insider transactions.